Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age11-17
SponsorTexas A&M University

About this trial

This pilot randomized controlled study will plan to enroll 36 adolescent females with Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS) to evaluate the effectiveness and feasibility of a tailored dietary intervention which will be termed "Beef+", that will emphasize the incorporation of unprocessed, lean beef (\<10% fat) as part of a healthy meal plan to improve glycemic control, diet quality, and health-related quality of life

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female Adolescent

11-17 years old

Suspected or confirmed diagnosis of PCOS

≥1-year post-menarche

Disqualifiers

Medications affecting glucoregulation, metabolic health, and/or appetite (e.g., metformin, GLP-1)

Unable or unwilling to eat beef

Pregnant or planning pregnancy during study

HbA1c ≥6.5%

Trial design

Design model

Parallel

Treatments tested in this trial

  • Beef+

    Other intervention

    Adolescents will be instructed to consume a minimum of 1 (3oz) serving per day of cooked unprocessed, lean (\<10% fat) beef (21 oz/week) for 12 weeks. To facilitate adoption, the intervention will be offered at the household level, but it is not a requirement. The intervention is a multi-modal behavior change intervention with three overarching components: modifying beef intake, consuming beef in healthy meals, and the research team purchasing the beef needed for the intervention. To facilitate adoption of lean beef as part of a healthy diet, a study RDN will meet with the participant and at least one representative parent/guardian at bi-weekly check-ins to provide tailored dietary support and develop an implementation plan. A financial supplement of $100/month will be provided offset grocery costs.

Treatment groups

36 Participants
are divided into 2 treatment groups
Group A: Control/Usual Lifestyle with optional Delayed InterventionNo intervention 0 interventions
Group B: Beef+Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in HbA1c

HbA1c measured as point of care using A1CNow+ point-of-care analyzer, HbA1c will also serve as a safety endpoint.

Time frame
Baseline, Week 6 and Week 12 of Intervention or Usual Lifestyle

Secondary outcomes

1

Change in 2-hour Fasting Glucose

Derived from a 75g oral glucose tolerance test (OGTT) as a measure of glycemic variability

Time frame
Baseline and Week 12 of Intervention or Usual Lifestyle
2

Dropout rate

Drop-out and the reason for drop-out will be recorded, and in both the intervention and usual lifestyle groups will be reported.

Time frame
Baseline and Week 12 of Intervention or Usual Lifestyle
3

Change in Matsuda Index

Derived from a 75g oral glucose tolerance test (OGTT), measure of insulin sensitivity

Time frame
Baseline and Week 12 of Intervention or Usual Lifestyle
4

Change in Insulinogenic Index

Derived from the 75g oral glucose tolerance test (OGTT), measure of insulin sensitivity

Time frame
Baseline and Week 12 of Intervention or Usual Lifestyle

Other outcomes

1

Compliance- Lean beef intake by self-report

Intake of lean beef, assessed via 24-hour diet recalls

Time frame
Baseline and Week 12 of Intervention or Usual Lifestyle
2

Compliance - Daily Survey

Intake of lean beef, assessed through daily logs of beef intake by providing portion sized objects that align with serving sizes and ask participants to take photos of their meals with the portion estimator, to ensure that both the meal planning is followed and portion sizes are met.

Time frame
Baseline and Week 12 of Intervention or Usual Lifestyle
3

Compliance - Blood Biomarkers

Serum hemoglobin will also be assessed as a metric of compliance.

Time frame
Baseline and Week 12 of Intervention or Usual Lifestyle
4

Participants' Quality of Life

This will be measured through the Pediatric Quality of Life (PedsQL) questionnaire. It includes 23 questions and is scored by reverse-scoring items and linearly transforming them to a 0-100 scale. Higher scores mean better health-related quality of life.

Time frame
Baseline and and Week 14

Sponsors and contacts

Click on the lead sponsor to view all of their trials.